產品編號 | bs-43191P |
英文名稱 | Recombinant human F2 protein, C-His (HEK293) |
中文名稱 | 重組人異常凝血酶原/脫-γ-羧基凝血酶原蛋白 |
別 名 | Des-gamma-carboxy (abnormal)prothrombin; Des-Gamma-carboxy-prothrombin; coagulation factor II (thrombin); Coagulation factor II; DCP; Factor II; Prepro coagulation factor II; Prothrombin; prothrombin B-chain; PT; RPRGL2; serine protease; THPH1; THRB; THRB_HUMAN; Thrombin heavy chain. |
理論分子量 | 31.6kDa |
性 狀 | Lyophilized or Liquid |
濃 度 | >0.5mg/ml |
物 種 | Human |
純 度 | >90% as determined by SDS-PAGE |
純化方法 | AC |
內毒素 | Not analyzed |
表達系統 | HEK293 cell |
標簽 | C-His |
緩 沖 液 | PBS (pH=7.4) |
保存條件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
注意事項 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
產品介紹 | Des-gamma carboxyprothrombin (DCP), also known as protein induced by vitamin K absence/antagonist-II (PIVKA-II), is an abnormal form of the coagulation protein, prothrombin. Normally, the prothrombin precursor undergoes post-translational carboxylation (addition of a carboxylic acid group) by gamma-glutamyl carboxylase in the liver prior to secretion into plasma. DCP/PIVKA-II may be detected in people with deficiency of vitamin K (due to poor nutrition or malabsorption) and in those taking warfarin or other medication that inhibits the action of vitamin K. SWISS: P00734 Gene ID: 2147 正常肝細胞中,在內質網內可將DCP羧化使之成為有活性的凝血酶原,一旦機體需要,凝血酶原即可轉變成凝血酶參與機體的各項生理功能,當有腫瘤細胞發生時,DCP明顯升高。DCP主要用于肝癌方面的研究;有學者認為:聯合應用DCP和AFP對于早期診斷HCC(原發性肝細胞癌)有較大的幫助。 |
產品圖片 | |
我要詢價
*聯系方式:
(可以是QQ、MSN、電子郵箱、電話等,您的聯系方式不會被公開)
*內容: